Download Our App
Select Page
Contact Us Today

"*" indicates required fields

Hidden
Hidden
This field is for validation purposes and should be left unchanged.

By: Suzanne Bruce, MD

We have just introduced a new botulinum toxin named Jeuveau™. It was approved by the Food & Drug Administration (FDA) to improve the look of moderate to severe frown lines between the eyebrows – what are known as the glabellar lines – for a period of time. Along with a select group of dermatologists and plastic surgeons, I attended the launch meeting where Evolus, the maker of Jeuveau, presented and discussed the science behind this new treatment.

What’s different about this new botulinum toxin and how long will it last? Evolus conducted a head-to-head trial of Jeuveau vs. BOTOX® Cosmetic. A total of 540 adult patients participated in the study. It showed that Jeuveau was safe, effective and equivalent to Botox for the treatment of moderate to severe frown lines. In a number of the parameters studied there was a trend in favor of Jeuveau over Botox, but they did not reach statistical significance. This trend suggests that this new toxin might last slightly longer than Botox. However, more studies need to be done to confirm that finding.

Evolus believes the differentiating factors are that Jeuveau was developed for and the company is exclusively dedicated to aesthetics. With that singular focus, Jeuveau is the first but not likely the last product we’ll see from this company. Evolus also touts its patented Hi-Pure™ technology that utilizes a modern manufacturing process to ensure product quality and safety.

We are offering a special price of $12 per unit to patients to try this new solution for the temporary improvement in the appearance of wrinkles before its official launch. As part of this introduction, patients are asked to complete two quick online surveys approximately a month apart to provide feedback to Evolus and us on their experience with new Jeuveau.
If you would like to try Jeuveau at a great price and see for yourself how well it works, set up your appointment today at 713-850-0240. We will officially launch this new treatment at our Get to Know Jeuveau Day June 20th, learn more here.

About Suzanne Bruce, M.D.

©2017 Al Torres Photo

Dr. Bruce is President of Suzanne Bruce and Associates, P.A. She has been practicing dermatology since 1985. A graduate of Rice University and Baylor College of Medicine, she completed her dermatology residency training at Baylor. She is certified by the American Board of Dermatology and a Fellow of the American Academy of Dermatology. She is a member of the American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, Texas Dermatological Society, and Houston Dermatological Society. She is also a member of the Leaders Society of the Dermatology Foundation. Dr. Bruce is a former Vice President of the Texas Dermatological Society and a former President of the Houston Dermatological Society.

Dr. Bruce serves as a consultant and trainer for leading drug, cosmeceutical, and laser companies. She has been recognized for excellence by many organizations and publications, including Texas Monthly (voted a Super Doctor, 2005-2018), Houstonia (voted a Top Doctor, 2013), H Texas (voted a Top Doctor, 2014-2015, 2017), Living Magazine Ful-shear Edition (Best Dermatologist 2017) and Houston Woman Magazine (one of Houston’s 50 Most Influential Women in 2009).

Learn more about Dr. Bruce and what matters most to her when creating a treatment plan for dermatology patients.

Read real patient reviews of Dr. Bruce on RealSelf

Find Dr. Suzanne Bruce on Google+